Figure 6.
Differentially methylated CpGs/regions in Alu and LINE-1. (A) Scatter plot comparing extended CpGs in Alu and LINE-1 between breast tumor and matched normal tissue; significant differences at Bonferroni P < 0.05 are colored and n is the number of CpGs (orange: hypermethylated; blue: hypomethylated). (B) Genome-wide break down of all CpGs tested, bumps formed using bumphunter, and significant DMR (FWER < 0.05) identified in breast cancer. Genomic distribution of extended CpGs was similar to profiled and identified more DMR of interest, especially in the intron and intergenic regions.